← Back to Search

Antioxidant

Pomegranate Supplement for Burnout

N/A
Waitlist Available
Led By Joshua Mann, MD, MPH
Research Sponsored by University of Mississippi Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 4 weeks, 8 weeks

Summary

This trial will test if taking pomegranate supplements can help reduce stress and improve well-being in medical students and residents who experience high levels of mental distress and burnout.

Who is the study for?
This trial is for first or second year medical students and residents at the University of Mississippi Medical Center. It's not suitable for those who are pregnant, planning to become pregnant, breastfeeding, taking chronic medications (other than contraception), using supplements, allergic to pomegranate or gelatin, or have severe depression or anxiety based on DASS-21 scores.
What is being tested?
The study tests if Pomella pomegranate extract can reduce stress and improve well-being in medical trainees compared to a placebo. Participants will be randomly assigned to receive either the supplement or an inactive substance without knowing which one they're getting.
What are the potential side effects?
Pomegranate extract may cause digestive discomfort or allergic reactions in some individuals. However, since it's a natural antioxidant supplement, serious side effects are less common compared to pharmaceutical drugs.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 4 weeks, 8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 4 weeks, 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Changes in Scores on Maslach Burnout Inventory over time
Changes in fatigue as measured by the Iowa Fatigue Scale over time
Changes in health as measured by scores on the RAND Short-Form 12 over time
+1 more
Secondary study objectives
Change in Serum total antioxidant capacity over time
Change in TREG cytokine levels from peripheral blood and culture supernatants over time
Change in Th1 cytokine levels from peripheral blood and culture supernatants
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Pomegranate SupplementExperimental Treatment1 Intervention
Participants in this arm will take a capsule with 500 mg of "Pomella" pomegranate extract twice each day for 28 days.
Group II: PlaceboPlacebo Group1 Intervention
Participants in this arm will take a gelatin placebo capsule twice each day for 28 days.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for burnout often focus on reducing oxidative stress and inflammation, which are key contributors to the condition. Antioxidants, like those found in pomegranate, neutralize free radicals and reduce oxidative stress, thereby decreasing inflammation and cellular damage. This mechanism is important for burnout patients as it helps alleviate physiological stress, improving overall well-being and mental health, and addressing the fatigue and mental distress associated with burnout.
Maternal pomegranate juice intake and brain structure and function in infants with intrauterine growth restriction: A randomized controlled pilot study.Melatonin treatment maintains nutraceutical properties of pomegranate fruits during cold storage.Cardioprotective Effects of Pomegranate (Punica granatum) Juice in Patients with Ischemic Heart Disease.

Find a Location

Who is running the clinical trial?

University of Rhode IslandOTHER
56 Previous Clinical Trials
22,321 Total Patients Enrolled
University of Mississippi Medical CenterLead Sponsor
180 Previous Clinical Trials
196,841 Total Patients Enrolled
Joshua Mann, MD, MPHPrincipal InvestigatorUniversity of Mississippi Medical Center

Media Library

Pomella pomegranate extract (Antioxidant) Clinical Trial Eligibility Overview. Trial Name: NCT03063372 — N/A
Burnout Research Study Groups: Placebo, Pomegranate Supplement
Burnout Clinical Trial 2023: Pomella pomegranate extract Highlights & Side Effects. Trial Name: NCT03063372 — N/A
Pomella pomegranate extract (Antioxidant) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03063372 — N/A
~1 spots leftby Feb 2025